Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.060
+0.010 (0.49%)
Jan 21, 2025, 4:00 PM EST - Market closed
NMRA's stock price has decreased by -85.54% in the past year and price targets may not have had time to catch up.
Neumora Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$20.67
Upside
+903.40%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $22 → $7 | Strong Buy | Maintains | $22 → $7 | +239.81% | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,356.31% | Jan 3, 2025 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,016.50% | Jan 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,356.31% | Dec 16, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $29 | Buy | Reiterates | $29 | +1,307.77% | Nov 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,356.31% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,016.50% | Nov 13, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $18 → $15 | Buy → Hold | Downgrades | $18 → $15 | +628.16% | Nov 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,016.50% | Oct 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +1,356.31% | Oct 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,016.50% | Sep 12, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $29 | Buy | Reiterates | $29 | +1,307.77% | Sep 4, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,016.50% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +1,016.50% | Jul 22, 2024 |
| Mizuho | Mizuho | Buy Initiates $20 | Buy | Initiates | $20 | +870.87% | Jul 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +1,404.85% | Mar 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.